CN108096359A - A kind of itching analgesic ointment and preparation method thereof - Google Patents
A kind of itching analgesic ointment and preparation method thereof Download PDFInfo
- Publication number
- CN108096359A CN108096359A CN201711483807.5A CN201711483807A CN108096359A CN 108096359 A CN108096359 A CN 108096359A CN 201711483807 A CN201711483807 A CN 201711483807A CN 108096359 A CN108096359 A CN 108096359A
- Authority
- CN
- China
- Prior art keywords
- parts
- extracting solution
- ointment
- water
- capsaicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000003251 Pruritus Diseases 0.000 title claims abstract description 21
- 239000002674 ointment Substances 0.000 title claims abstract description 17
- 230000000202 analgesic effect Effects 0.000 title claims abstract description 15
- 230000007803 itching Effects 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- 239000007788 liquid Substances 0.000 claims abstract description 31
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000003921 oil Substances 0.000 claims abstract description 22
- 244000048199 Hibiscus mutabilis Species 0.000 claims abstract description 19
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims abstract description 18
- 229960002504 capsaicin Drugs 0.000 claims abstract description 18
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 17
- 241001645380 Bassia scoparia Species 0.000 claims abstract description 16
- 235000003973 Hibiscus mutabilis Nutrition 0.000 claims abstract description 16
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 16
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 13
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 13
- 240000000774 Cunila origanoides Species 0.000 claims abstract description 13
- 235000018274 Cunila origanoides Nutrition 0.000 claims abstract description 13
- 235000014866 Dictamnus albus Nutrition 0.000 claims abstract description 13
- 229940116229 borneol Drugs 0.000 claims abstract description 13
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 13
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 12
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 12
- 235000021355 Stearic acid Nutrition 0.000 claims abstract description 12
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000011187 glycerol Nutrition 0.000 claims abstract description 12
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract description 12
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000008117 stearic acid Substances 0.000 claims abstract description 12
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 11
- 239000004359 castor oil Substances 0.000 claims abstract description 11
- 235000019438 castor oil Nutrition 0.000 claims abstract description 11
- 239000008367 deionised water Substances 0.000 claims abstract description 11
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 11
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 11
- 239000004615 ingredient Substances 0.000 claims abstract description 10
- 229940064064 purslane extract Drugs 0.000 claims abstract description 10
- 239000003814 drug Substances 0.000 claims abstract description 7
- 239000003755 preservative agent Substances 0.000 claims abstract description 6
- 230000002335 preservative effect Effects 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims abstract description 4
- 238000000605 extraction Methods 0.000 claims description 14
- 239000003883 ointment base Substances 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 7
- 239000008236 heating water Substances 0.000 claims description 6
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims description 2
- 238000002390 rotary evaporation Methods 0.000 claims description 2
- 229960001777 castor oil Drugs 0.000 claims 3
- 239000000047 product Substances 0.000 claims 2
- 244000234609 Portulaca oleracea Species 0.000 claims 1
- 240000000528 Ricinus communis Species 0.000 claims 1
- 235000004443 Ricinus communis Nutrition 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 238000005260 corrosion Methods 0.000 claims 1
- 238000002242 deionisation method Methods 0.000 claims 1
- 239000012467 final product Substances 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000007794 irritation Effects 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 10
- 230000036407 pain Effects 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 235000005206 Hibiscus Nutrition 0.000 description 4
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 4
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- ADNPLDHMAVUMIW-CUZNLEPHSA-N substance P Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 ADNPLDHMAVUMIW-CUZNLEPHSA-N 0.000 description 4
- 230000036592 analgesia Effects 0.000 description 3
- 230000001139 anti-pruritic effect Effects 0.000 description 3
- 239000003908 antipruritic agent Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 206010058019 Cancer Pain Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000004404 Intractable Pain Diseases 0.000 description 1
- 244000228367 Lewisia rediviva Species 0.000 description 1
- 235000007279 Lewisia rediviva Nutrition 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 102000003797 Neuropeptides Human genes 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219304 Portulacaceae Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 229940096978 oral tablet Drugs 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a kind of itching analgesic ointment, including following components in parts by weight:10 15 parts of stearic acid, 7 13 parts of castor oil, 10 15 parts of atoleine are oil phase;0.5 3 parts of triethanolamine is emulsifier;38 parts of glycerine, 45 55 parts of deionized water, 0.5 2 parts of borneol, 0.1 1 parts of frutus cnidii extracting solution, 0.1 1 parts of Purslane extract, 0.1 1 parts of pericarpium zanthoxyli extracting solution, 0.1 1 parts of Radix Notoginseng extracting solution, 0.1 1 parts of root bark of shaggy-fruited dittany extracting solution, 0.1 1 parts of Folium Artemisiae Argyi extractive liquid, 0.1 1 parts of cotton rose extracting solution, 0.1 1 parts of fruit of summer cypress extracting solution, 0.01 1 parts of capsaicine are water phase and its both effectiveness ingredient;Outstanding 0.1 1 parts of horse antiseptic is preservative, the beneficial effects of the invention are as follows:The ointment has merged the effect of a variety of traditional Chinese medicine extracts ingredient, is also added into the fabulous capsaicine of itching analgesic effect, and irritation is small during use, and effect is rapid, and therapeutic effect is notable.
Description
Technical field
The present invention relates to a kind of itching analgesic ointment, are specifically a kind of itching analgesic ointment and preparation method thereof.
Background technology
Cutaneous pruritus refers to the clinically skin disease based on itch without the damage of apparent primary cutaneous.Itch is often
Many systemic property diseases occur together or onset symptoms, disease Fa Shiqi itch unbearably, traditional antipruritic method is usually palliative,
Slowly effect, repeatability is strong, obstinate.
Pain can be divided into Acute Pain, chronic ache, intractable pain, cancer pain and special pain.Common analgesia
Class pharmaceutical dosage form has oral tablet, patch and spraying etc., and the drug medication amount of the type is big, takes effect slowly, there are other poison are secondary
Effect.
The content of the invention
It is an object of the invention to provide a kind of itching analgesic ointment and preparation method thereof, to solve in above-mentioned background technology
The problem of proposition.
To achieve the above object, the present invention provides following technical solution:
A kind of itching analgesic ointment, including following components in parts by weight:10-15 parts of stearic acid, 7-13 parts of castor oil,
10-15 parts of atoleine is oil phase;0.5-3 parts of triethanolamine is emulsifier;3-8 parts of glycerine, 45-55 parts of deionized water, borneol
0.5-2 parts, 0.1-1 parts of frutus cnidii extracting solution, 0.1-1 parts of Purslane extract, 0.1-1 parts of pericarpium zanthoxyli extracting solution, Radix Notoginseng extracting solution
0.1-1 parts, 0.1-1 parts of root bark of shaggy-fruited dittany extracting solution, 0.1-1 parts of Folium Artemisiae Argyi extractive liquid, 0.1-1 parts of cotton rose extracting solution, the fruit of summer cypress extraction
0.1-1 parts of liquid, 0.01-1 parts of capsaicine are water phase and its both effectiveness ingredient;Outstanding 0.1-1 parts of horse antiseptic is preservative.
As further embodiment of the present invention:Including following components in parts by weight:11-14 parts of stearic acid, castor oil
8-12 parts, 11-14 parts of atoleine be oil phase;1.5-2 parts of triethanolamine is emulsifier;4-7 parts of glycerine, deionized water 47-53
Part, 1-1.5 parts of borneol, 0.4-0.7 parts of frutus cnidii extracting solution, 0.4-0.7 parts of Purslane extract, pericarpium zanthoxyli extracting solution 0.4-0.7
Part, 0.4-0.7 parts of Radix Notoginseng extracting solution, 0.4-0.7 parts of root bark of shaggy-fruited dittany extracting solution, 0.4-0.7 parts of Folium Artemisiae Argyi extractive liquid, cotton rose extracting solution
0.4-0.7 parts, 0.4-0.7 parts of fruit of summer cypress extracting solution, 0.1-0.91 parts of capsaicine be water phase and its both effectiveness ingredient;Outstanding horse antibacterial
0.4-0.7 parts of agent is preservative.
As further scheme of the invention:Including following components in parts by weight:12 parts of stearic acid, castor oil 10
Part, 12 parts of atoleine are oil phase;1.7 parts of triethanolamine is emulsifier;5 parts of glycerine, 50 parts of deionized water, 1.3 parts of borneol, snake
0.5 part of machine tool extracting solution, 0.5 part of Purslane extract, 0.5 part of pericarpium zanthoxyli extracting solution, 0.5 part of Radix Notoginseng extracting solution, root bark of shaggy-fruited dittany extraction
0.5 part of liquid, 0.5 part of Folium Artemisiae Argyi extractive liquid, 0.5 part of cotton rose extracting solution, 0.5 part of fruit of summer cypress extracting solution, 0.5 part of capsaicine are water phase
And its both effectiveness ingredient;Outstanding 0.5 part of horse antiseptic is preservative.
A kind of preparation method of itching analgesic ointment, comprises the following steps:
S1, the preparation of Chinese medicine extract
(1) preparation of fruit of summer cypress extracting solution:It is 1 by solid-liquid ratio by the fruit of summer cypress and 95% ethanol solution:10 proportioning into
Row addition, the heating water bath 1.5h at 80 DEG C recycle fraction, in triplicate, finally merge extracting solution three times, utilize rotary evaporation
Instrument concentrated to get;
(2) preparation of pericarpium zanthoxyli extracting solution:It is 1 by solid-liquid ratio by pericarpium zanthoxyli and 70% ethanol solution:20 proportioning is added
Add, the heating water bath 1h at 60 DEG C, recycle fraction, in triplicate, finally merge extracting solution three times, using Rotary Evaporators by its
Concentration to get;
(4) preparation of cottonrose hibiscus flower extracting solution:It is 1 by solid-liquid ratio by cottonrose hibiscus flower and 50% ethanol solution:10 match somebody with somebody
Than being added, the heating water bath 1.5h at 70 DEG C recycles fraction, in triplicate, finally merges extracting solution three times, utilize rotation
Evaporimeter concentrated to get;
Remaining extracting solution is the finished product directly bought;
S2, the preparation of ointment bases
The stearic acid, castor oil and atoleine of above-mentioned parts by weight are weighed as oil phase, then weighs above-mentioned parts by weight
As water phase, triethanolamine is emulsifier for several glycerine and deionized water, by water phase and oil phase be respectively placed in 80 DEG C of water-baths into
Row heating, after it is completely dissolved, slowly mutually pours into water in oil phase, adds in emulsifier afterwards and is constantly stirred straight
To complete emulsification to get ointment bases;
It is prepared by S3, finished product
By borneol, capsaicine, fruit of summer cypress extracting solution, pericarpium zanthoxyli extracting solution, cottonrose hibiscus flower extracting solution, frutus cnidii extracting solution, horse
Bitterroot extracting solution, Radix Notoginseng extracting solution, root bark of shaggy-fruited dittany extracting solution and Folium Artemisiae Argyi extractive liquid, are placed in beaker according to above-mentioned parts by weight, stir
It mixes and is mixed into extraction liquid mixture, when the ointment bases in step S2 is cooled to 40 DEG C, extraction liquid mixture is slowly added to
Being stirred continuously in ointment bases makes it uniformly, added in during stirring outstanding horse antiseptic to get;
S4 is packed and stored after the finished product that S3 is obtained is dispensed.
It is as follows the effect of fractions in the present invention:
Borneol:Antibacterial, anti-inflammatory effect, higher concentration (0.5%) is to staphylococcus, streptococcus, the double ball mattresses of pneumonia, large intestine bar
Pathogenic dermatophyte of bacterium and part etc. has inhibitory action;
Frutus cnidii:Energy removing dampness and destroying parasites, treats eczema, allergic dermatitis;
Purslane:Clearing heat and detoxicating, Li Shui dries, and dissipates blood detumescence, dust-collection sterilization, anti-inflammatory analgetic, blood-stanching and blood-cooling.Cure mainly dysentery
Disease, enteritis, ephritis, postpartum uterine hemorrhage are had blood in stool, the illnesss such as mastitis;
Pericarpium zanthoxyli:Except the stink smell of various meats;Promote salivary secretion, increase appetite;It distends the blood vessels, so as to play reduction blood
The effect of pressure;Parasite can be removed by taking pepper water;There are fragrant stomach invigorating, warming spleen and stomach for dispelling cold, damp dispelling and pain relieving, desinsection removing toxic substances, antipruritic solution raw meat
The effect of;
Radix Notoginseng:Hemoptysis spits blood, has blood in stool, uterine bleeding, traumatic hemorrhage;Treating swelling and pain by traumatic injury and Blood stasis;
The root bark of shaggy-fruited dittany:Antibacterial, antitumaous effect have certain influence to cardiovascular system and blood;
Folium artemisiae argyi:Folium artemisiae argyi is in vitro to bacillus anthracis, Alpha-hemolytic streptococcus, B- Streptococcus hemolyticus, corynebacterium diphtheriae, false diphtheria bar
10 kinds of gram sun such as bacterium, Diplococcus pneumopniae, gold-coloured staphylococci, Staphylococcus citreus, staphylococcus aureus, hay bacillus
Property aerophil all has antibacterial action.Also there is hemostasis, it is antimycotic, it relievings asthma, cholagogic, antiallergy and other effects;
Cottonrose hibiscus flower:Cotton rose can be clearing heat and detoxicating, can be used in treating cough with lung heat, Nv Xingbai with cooling blood and hemostasis
Band and menorrhalgia etc. can also carry out external application, have to treatment traumatic injury, burn and scald, mastitis, lymph inflammation etc. certain
Effect also has effects that detumescence and apocenosis.Containing certain effective ingredient such as brass glucoside, anthocyanin etc. in cotton rose, use
It spends the ointment that 20% is made into plus vaseline, can treat local infection;
The fruit of summer cypress:Diuresis, clearing away damp-heat.Control difficult urination, gonorrhoea, under band, hernia, rubella, sore, mange;
Capsaicine:Capsaicine is mainly to synthesize and store to play analgesia and block by influencing the release of neuropeptide substance p
Effect.Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 is a kind of 11 peptides, is a kind of important nerve conduction medium, pain and itch can be passed to by peripheral nerve
Spinal nerve and high-level center nerve.Capsaicine mainly acts on the Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 in c-type sensory neuron, and the conductive skin pain sensation
With some in the exactly c-type nerve fibre of ill itch without the slow Conductive fiber of marrow.Local topical capsaicine acts on periphery god
Through aixs cylinder, cause the reduction from all neurons (periphery and maincenter) Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2, so as to fulfill analgesia and it is antipruritic the effect of.It is suitable
For short-term relief muscle as caused by rheumatism and the mild pain and back pain and strain in joint, pull caused pain
Bitterly.
Compared with prior art, the beneficial effects of the invention are as follows:The present invention has dispelling wind and arresting itching, promoting blood circulation to remove blood stasis, and detumescence stops
The effect of pain, available for treating the symptoms such as common neurodermatitis, pruitus, herpes zoster, traumatic injury.The ointment melts
The effect of having closed a variety of traditional Chinese medicine extracts ingredient, is also added into the fabulous capsaicine of itching analgesic effect, and when use stimulates
Property it is small, effect is rapid, and therapeutic effect is notable.
Specific embodiment
The technical solution of this patent is described in more detail With reference to embodiment.
Embodiment 1
10 parts of stearic acid, 7 parts of castor oil, 10 parts of atoleine are weighed as oil phase;45 parts of 3 parts of glycerine, deionized water works
For water phase, 0.5 part of triethanolamine is emulsifier, and above-mentioned oil phase is mutually placed in 80 DEG C of water-baths with water and is heated, and treats it completely
After dissolving, slowly water is mutually poured into oil phase, afterwards add in emulsifier and be constantly stirred until completely emulsify to get
Ointment bases;By 0.5 part of borneol, 0.1 part of frutus cnidii extracting solution, 0.1 part of Purslane extract, 0.1 part of pericarpium zanthoxyli extracting solution, Radix Notoginseng
0.1 part of extracting solution, 0.1 part of root bark of shaggy-fruited dittany extracting solution, 0.1 part of Folium Artemisiae Argyi extractive liquid, 0.1 part of cotton rose extracting solution, fruit of summer cypress extracting solution
0.1 part, 0.01 part of capsaicine be placed in beaker, be stirred into extraction liquid mixture, when ointment bases is cooled to 40 DEG C, will
Extraction liquid mixture, which is slowly added to be stirred continuously in ointment bases, makes it uniformly, and outstanding horse antiseptic is added in during stirring
It 0.1 part, is packed and is stored after then finished product is dispensed.
Embodiment 2
Claim 15 parts of stearic acid, take 13 parts of castor oil, 15 parts of atoleine as oil phase;55 parts of 8 parts of glycerine, deionized water works
For water phase, 3 parts of triethanolamine is emulsifier, and above-mentioned oil phase is mutually placed in 80 DEG C of water-baths with water and is heated, and treats that it is completely molten
Xie Hou slowly mutually pours into water in oil phase, adds in emulsifier afterwards and is constantly stirred until emulsification is to get soft completely
Cream base matter;By 2 parts of borneol, 1 part of frutus cnidii extracting solution, 1 part of Purslane extract, 1 part of pericarpium zanthoxyli extracting solution, 1 part of Radix Notoginseng extracting solution,
1 part of root bark of shaggy-fruited dittany extracting solution, 1 part of Folium Artemisiae Argyi extractive liquid, 1 part of cotton rose extracting solution, 1 part of fruit of summer cypress extracting solution, 1 part of capsaicine are placed in burning
In cup, extraction liquid mixture is stirred into, when ointment bases is cooled to 40 DEG C, extraction liquid mixture is slowly added to ointment
Being stirred continuously in matrix makes it uniformly, and outstanding 1 part of horse antiseptic is added in during stirring, is wrapped after then finished product is dispensed
Dress and storage.
Embodiment 3
Claim 12 parts of stearic acid, take 10 parts of castor oil, 12 parts of atoleine as oil phase;50 parts of 5 parts of glycerine, deionized water works
For water phase, 1.7 parts of triethanolamine is emulsifier, and above-mentioned oil phase is mutually placed in 80 DEG C of water-baths with water and is heated, and treats it completely
After dissolving, slowly water is mutually poured into oil phase, afterwards add in emulsifier and be constantly stirred until completely emulsify to get
Ointment bases;By 1.3 parts of borneol, 0.5 part of frutus cnidii extracting solution, 0.5 part of Purslane extract, 0.5 part of pericarpium zanthoxyli extracting solution, Radix Notoginseng
0.5 part of extracting solution, 0.5 part of root bark of shaggy-fruited dittany extracting solution, 0.5 part of Folium Artemisiae Argyi extractive liquid, 0.5 part of cotton rose extracting solution, fruit of summer cypress extracting solution
0.5 part, 0.5 part of capsaicine be placed in beaker, be stirred into extraction liquid mixture, when ointment bases is cooled to 40 DEG C, will
Extraction liquid mixture, which is slowly added to be stirred continuously in ointment bases, makes it uniformly, and outstanding horse antiseptic 1 is added in during stirring
Part, it is packed and is stored after then finished product is dispensed.
Through clinical test case 30, continuous medication is after 30 days, statistical result showed, wherein 16 are cured, effective 9,
Effective 2, invalid or exacerbation 2.Wherein total effective rate is 93%.Using this product without any side effects such as toxic, harmful, and
Therapeutic effect is notable.
It is obvious to a person skilled in the art that the invention is not restricted to the details of above-mentioned exemplary embodiment, Er Qie
In the case of without departing substantially from spirit or essential attributes of the invention, the present invention can be realized in other specific forms.Therefore, no matter
From the point of view of which point, the present embodiments are to be considered as illustrative and not restrictive, and the scope of the present invention is by appended power
Profit requirement rather than above description limit, it is intended that all by what is fallen within the meaning and scope of the equivalent requirements of the claims
Variation is included within the present invention.
Moreover, it will be appreciated that although this specification is described in terms of embodiments, but not each embodiment is only wrapped
Containing an independent technical solution, this description of the specification is merely for the sake of clarity, and those skilled in the art should
Using specification as an entirety, the technical solutions in each embodiment can also be properly combined, forms those skilled in the art
It is appreciated that other embodiment.
Claims (4)
1. a kind of itching analgesic ointment, which is characterized in that including following components in parts by weight:10-15 parts of stearic acid, castor-oil plant
7-13 parts oily, 10-15 parts of atoleine is oil phase;0.5-3 parts of triethanolamine is emulsifier;3-8 parts of glycerine, deionized water 45-
55 parts, 0.5-2 parts of borneol, 0.1-1 parts of frutus cnidii extracting solution, 0.1-1 parts of Purslane extract, 0.1-1 parts of pericarpium zanthoxyli extracting solution, three
Seven 0.1-1 parts of extracting solutions, 0.1-1 parts of root bark of shaggy-fruited dittany extracting solution, 0.1-1 parts of Folium Artemisiae Argyi extractive liquid, 0.1-1 parts of cotton rose extracting solution,
0.1-1 parts of skin extracting solution, 0.01-1 parts of capsaicine are water phase and its both effectiveness ingredient;Outstanding 0.1-1 parts of horse antiseptic is anti-corrosion
Agent.
2. a kind of itching analgesic ointment according to claim 1, which is characterized in that including in parts by weight with the following group
Point:11-14 parts of stearic acid, 8-12 parts of castor oil, 11-14 parts of atoleine are oil phase;1.5-2 parts of triethanolamine is emulsifier;
4-7 parts of glycerine, 47-53 parts of deionized water, 1-1.5 parts of borneol, 0.4-0.7 parts of frutus cnidii extracting solution, Purslane extract 0.4-
0.7 part, 0.4-0.7 parts of pericarpium zanthoxyli extracting solution, 0.4-0.7 parts of Radix Notoginseng extracting solution, 0.4-0.7 parts of root bark of shaggy-fruited dittany extracting solution, folium artemisiae argyi extraction
0.4-0.7 parts of liquid, 0.4-0.7 parts of cotton rose extracting solution, 0.4-0.7 parts of fruit of summer cypress extracting solution, 0.1-0.91 parts of capsaicine are water
Phase and its both effectiveness ingredient;Outstanding 0.4-0.7 parts of horse antiseptic is preservative.
3. a kind of itching analgesic ointment according to claim 1, which is characterized in that include following components in parts by weight:
12 parts of stearic acid, 10 parts of castor oil, 12 parts of atoleine are oil phase;1.7 parts of triethanolamine is emulsifier;5 parts of glycerine, deionization
50 parts of water, 1.3 parts of borneol, 0.5 part of frutus cnidii extracting solution, 0.5 part of Purslane extract, 0.5 part of pericarpium zanthoxyli extracting solution, Radix Notoginseng extraction
0.5 part of liquid, 0.5 part of root bark of shaggy-fruited dittany extracting solution, 0.5 part of Folium Artemisiae Argyi extractive liquid, 0.5 part of cotton rose extracting solution, fruit of summer cypress extracting solution 0.5
Part, 0.5 part of capsaicine are water phase and its both effectiveness ingredient;Outstanding 0.5 part of horse antiseptic is preservative.
4. a kind of a kind of preparation method of itching analgesic ointment as described in claim 1-3 is any, which is characterized in that including with
Lower step:
S1, the preparation of Chinese medicine extract
(1)The preparation of fruit of summer cypress extracting solution:It is 1 by solid-liquid ratio by the fruit of summer cypress and 95% ethanol solution:10 proportioning is added
Add, the heating water bath 1.5h at 80 DEG C, recycle fraction, in triplicate, finally merge extracting solution three times, it will using Rotary Evaporators
Its concentrate to get;
(2)The preparation of pericarpium zanthoxyli extracting solution:It is 1 by solid-liquid ratio by pericarpium zanthoxyli and 70% ethanol solution:20 proportioning is added,
Heating water bath 1h at 60 DEG C is recycled fraction, in triplicate, finally merges extracting solution three times, concentrated using Rotary Evaporators,
To obtain the final product;
(4)The preparation of cottonrose hibiscus flower extracting solution:It is 1 by solid-liquid ratio by cottonrose hibiscus flower and 50% ethanol solution:10 proportioning into
Row addition, the heating water bath 1.5h at 70 DEG C recycle fraction, in triplicate, finally merge extracting solution three times, utilize rotary evaporation
Instrument concentrated to get;
S2, the preparation of ointment bases
The stearic acid, castor oil and atoleine of above-mentioned parts by weight are weighed as oil phase, then weighs above-mentioned parts by weight
As water phase, triethanolamine is emulsifier for glycerine and deionized water, and water phase and oil phase are respectively placed in 80 DEG C of water-baths is added
Heat after it is completely dissolved, is slowly mutually poured into water in oil phase, adds in emulsifier afterwards and is constantly stirred until complete
Full milk is to get ointment bases;
It is prepared by S3, finished product
By borneol, capsaicine, fruit of summer cypress extracting solution, pericarpium zanthoxyli extracting solution, cottonrose hibiscus flower extracting solution, frutus cnidii extracting solution, purslane
Extracting solution, Radix Notoginseng extracting solution, root bark of shaggy-fruited dittany extracting solution and Folium Artemisiae Argyi extractive liquid, are placed according to above-mentioned parts by weight in beaker, and stirring is mixed
Extraction liquid mixture when the ointment bases in step S2 is cooled to 40 DEG C, is slowly added to ointment by synthesis extraction liquid mixture
Being stirred continuously in matrix makes it uniformly, added in during stirring outstanding horse antiseptic to get;
S4 is packed and stored after the finished product that S3 is obtained is dispensed.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711483807.5A CN108096359A (en) | 2017-12-29 | 2017-12-29 | A kind of itching analgesic ointment and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711483807.5A CN108096359A (en) | 2017-12-29 | 2017-12-29 | A kind of itching analgesic ointment and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108096359A true CN108096359A (en) | 2018-06-01 |
Family
ID=62214873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711483807.5A Pending CN108096359A (en) | 2017-12-29 | 2017-12-29 | A kind of itching analgesic ointment and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108096359A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105311195A (en) * | 2014-07-30 | 2016-02-10 | 高晓燕 | Formulation for treating cutaneous pruritus |
-
2017
- 2017-12-29 CN CN201711483807.5A patent/CN108096359A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105311195A (en) * | 2014-07-30 | 2016-02-10 | 高晓燕 | Formulation for treating cutaneous pruritus |
Non-Patent Citations (10)
| Title |
|---|
| J LYSY等: "Topical capsaicin—a novel and effective treatment", 《GUT》 * |
| 张光荣: "《当代皮肤科临床家丛书.第3辑.范瑞强》", 31 January 2017, 中国医药科技出版社 * |
| 彭成等: "《中药药理学》", 31 December 2014, 中国医药科技出版社 * |
| 杨俊玲等: "《药学概论》", 31 August 2014, 山东出版传媒股份有限公司 山东人民出版社 * |
| 杨德胜等: "《实用土家族药物》", 31 August 2016, 中国医药科技出版社 * |
| 杨闰平等: "皮肤瘙痒症血清P物质的检测及辣椒碱软膏的疗效观察", 《中国皮肤性病学杂志》 * |
| 深圳市金版文化发展有限公司: "《肝病居家疗法一本通》", 31 December 2008, 广州出版社 * |
| 王丽丽等: "辣椒碱软膏临床应用72例观察", 《中国现代药物应用》 * |
| 茅伟安: "《皮肤病用药速查手册》", 30 April 2014, 金盾出版社 * |
| 马振友: "《最新皮肤科药物手册》", 30 June 2008, 世界图书出版西安公司 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6027728A (en) | Herbal skin regeneration composition and method | |
| US6579543B1 (en) | Composition for topical application to skin | |
| CN103182045A (en) | Medicine for treating tinea of feet and hands and preparation method thereof | |
| CN104147533A (en) | Blood-activating, stasis-resolving and pain-relieving cream and preparation method thereof | |
| CN104258278B (en) | Gushangling (for bone injury) spray | |
| CN101313940B (en) | Traditional Chinese medicine nourishing skin-protection cream | |
| CN112237621B (en) | Traditional Chinese medicine emulsifiable paste for hyperplasia of mammary glands and preparation method thereof | |
| CN101396528B (en) | Traditional Chinese medicine composite preparation for treating wind-heat cold | |
| CN102716304B (en) | Traditional Chinese medicine preparation for treating dermatosis and preparation method thereof | |
| CN105126037B (en) | A kind of ointment for treating bone fracture and injury of the extract containing natural component and preparation method thereof | |
| CN105999105A (en) | Traditional Chinese medicine composition for treating bedsores and diabetic ulcers and preparation method thereof | |
| CN115518127B (en) | Antibacterial, anti-inflammatory, swelling, antipruritic cream and preparation method thereof | |
| CN108096359A (en) | A kind of itching analgesic ointment and preparation method thereof | |
| WO2018161890A1 (en) | Application of berberine in preparing drug for treating acute soft tissue injury | |
| CN110812377B (en) | Acne treatment and repair composition and application thereof | |
| Semkina | Ointments, gels, liniments, and creams containing phytopreparations (a review) | |
| CN110384785B (en) | A kind of external use traditional Chinese medicine liquid for treating viral cold and preparation method thereof | |
| CN113058018A (en) | Ointment for warming channel to dispel cold, promoting blood circulation and relieving pain | |
| CN114796322B (en) | Traditional Chinese medicine preparation for treating swelling and pain caused by injuries from falls and preparation method thereof | |
| CN116159086B (en) | Antibacterial, anti-inflammatory and antipruritic traditional Chinese medicine emulsifiable paste and preparation method thereof | |
| CN104873723B (en) | Cinnamon oil-containing medicine for treating burns and scalds | |
| CN114984084B (en) | Traditional Chinese medicine composition and traditional Chinese medicine preparation for treating hemorrhoid anorectal diseases and preparation method and application thereof | |
| CN103768213B (en) | A kind of Chinese medicine composition for the treatment of foot odor and preparation method thereof | |
| CN1212148C (en) | External plaster of sea horse and soft-shelled turtle | |
| CN102343018B (en) | Ointment for treating soft tissue sprain and contuse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180601 |